Antibodies. Rabbit anti-AP4M1 (GeneTex), anti-AP1M1, AP1M2 or AP2M1 (Abcam), and anti-GLuc (New England BioLabs) antibodies, or mouse anti-NS5B (BioFront Technologies), and anti-beta actin (Sigma-aldrich) antibodies. Rabbit monoclonal anti-NS2 antibodies were previously described (3).
RNA interference (RNAi).
Huh7.5 cells were transduced with lentiviral particles harboring shRNAs (Sigma). AP1M1, AP1M2, AP4M1 and AP2M1 were silenced via transduction with shRNA-expressing lentivirus (catalogue numbers: TRCN0000218336, TRCN0000141187, TRCN0000059718, TRCN0000060239 or Mission pLKO.1-puro non-mammalian shRNA control; Sigma-aldrich) and selection on 1 μg/ml puromycin. AP1M1 shRNA targeted a non-translated region whereas the other shRNAs targeted coding sequences.
Protein fragment complementation assays (PCAs).
PCAs in mammalian cells were conducted as described (3, 11, 12) . Briefly, combinations of plasmids encoding prey (A) and bait (B) proteins, each fused to a fragment of the Gaussia luciferase protein (GLuc1 and GLuc2) or control vectors were cotransfected into 293T cells plated in 96-well plates in triplicates. At 24 hours post-transfection, cells were lysed and subjected to luciferase assays (Promega). Results were expressed as normalized luminescence ratios (NLR): the average signal in cells transfected with GLuc1-A and GLuc2-B divided by the average signal in wells transfected with GLuc1-A and an empty GLuc2 vector and those transfected with GLuc2-B and an empty GLuc1 vector.
Live cell imaging. Huh7.5 cells were infected with concentrated HCV TC-core at MOI of 1 for 24 hours, then transfected with either AP-1A-, AP-1B-, AP-2-, or AP-4-mCherry using Lipofectamine2000 (Invitrogen) and seeded onto collagen coated 35 mm fluorodishes (World Precision Instruments) (8, 9) . At 72 hours post-infection, cells were labeled with biarsenical dye (1.25 μM) in Opti-MEM at 37 o C for 30 minutes, then washed three times with 1X BAL (2,3-dimercapto-1-propanol) wash buffer (Invitrogen) supplemented with 500 μM EDT in Opti-MEM. The cells were washed and incubated in prewarmed imaging media (DMEM-F12, Invitrogen) supplemented with 10% fetal bovine serum, 0.1 mM nonessential amino acids, 1% penicillin-streptomycin, and 25 mM HEPES. When specified, TC-core infected cells were incubated with DMSO or PIK93 (0.5 µM) for 3 hours beginning at 72 hours postinfection. Timelapse images were taken using a Leica SP5 II AOBS Tandem Scanner Spectral confocal microscope with a 100X 1.46 oil objective and a heated (37 o C) chamber. An average of 5 movies representing individual cells with trackable 15-30 puncta each were recorded per sample with sequential frames taken every 2 seconds. Individual core puncta run lengths and transport velocities were calculated using the Manual Tracking plugin for Image J, measuring the distance traveled (in any direction) between frames for a respective TC-core puncta.
Generation of AAK1-and GAK-knockout cell lines using CRISPR/Cas9. Single guide RNAs (sgRNA): AAK1: 5' CACCGCGGGCGACAGCAGGTCACAG and 5′ AAACCTGTGACCTGCTGTCGCCCGC site. GAK; 5' CACCGGCGACCAGAGTGACTTCGTG and 5' AAACCACGAAGTCACTCTGGTCGCC. The annealed oligos were cloned into pLentiCRISPR V2 plasmid following its digestion with FastDigest Esp3I (Thermo Fisher Scientific), as described (13) . These plasmids and a pLentiCRISPR V2 non-targeting (NT) control plasmid were cotransfected individually along with the packaging plasmids pCMV-R8.91 pMD.G (Addgene) into HEK293-F T cells (ATCC) for preparation of the lentiviruses. CRISPR sgRNA lentivirus targeting AAK1 or GAK and CRISPR NT control lentivirus were transduced individually into Huh7.5 cells followed by selection in 2 μg/mL puromycin (InvivoGen). Single cell-derived clones were used for the binding experiments.
Co-immunoprecipitations.
Co-IPs in membrane fractions derived from HCV RNA or GLuc-NS2 and AP-4 transfected cells were carried out as previously described (3, 12) . ∼20×10 6 Huh7.5 cells transfected with HCV J6/JFH RNA or GLuc-NS2 and AP-4 were collected by trypsinization 3 days post-transfection, washed once with PBS and incubated with 1mM dithiobis-succinimidyl-propionate (DSP) crosslinker (Pierce) solution for 2 hours on ice to allow covalent binding of the already bound interacting proteins. Tris (pH 7.5) was added at 20 mM for 15 minutes to quench unreacted DSP. Cells were washed once with PBS, resuspended in HME buffer (20 mM HEPES (pH 7.4), 1 mM EDTA, 2 mM MgCl2) supplemented with phenylmethylsulfonyl fluoride to a final concentration of 1 mM and a protease inhibitors cocktail (Sigma). Cells were lysed by two freeze-thaw cycles in dry ice/ethanol and then passaged through a 27.5-gauge needle 10 times. Nuclei were removed by centrifugation at 250×g for 10 minutes, and the postnuclear supernatant was subjected to ultracentrifugation at 100,000×g for 30 minutes. All steps were done at 4°C. Membrane pellets were resuspended in 100 µl HME buffer. TDB buffer (2.5% Triton X-100, 25 mM triethanolamine-Cl (pH 8.6), 20 mM NaCl, 5 mM EDTA, 0.2% NaN3) was added to a final volume of 1 ml. Samples were incubated overnight with protein G magnetic beads (Dynabeads, Life Technologies) crosslinked with either anti-AP, -NS2, -NS5B antibodies or IgG controls via bis(sulfosuccinimidyl)suberate (BS 3 ) crosslinker (Sulfo-DSS, Thermo Scientific Pierce). Following extensive washes, bound proteins were eluted from the beads by adding SDS sample buffer and heating for 10 minutes. Immunoprecipitates were analyzed by Western blotting. 
